Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: Open label study

World Journal of Gastroenterology

Volumn 14, Issue 25, 2008, Pages 4059-4064

  Matsumoto, Satohiro ^a   Tsuji, Kenichiro ^a   Shirahama, Satoshi ^a  

^a Kamigoto Hospital   (Japan)

Author keywords

Fasting; Hospitalization; Ischemic colitis; Rebamipide enema; Ulcer healing; White blood cells

Indexed keywords

ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; DIGITALIS; DIURETIC AGENT; REBAMIPIDE; ALANINE; DRUG DERIVATIVE; ENEMA; GASTROINTESTINAL AGENT; QUINOLONE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ULCER; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; FEMALE; FLUID THERAPY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC COLITIS; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; OPEN STUDY; REST; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; ULCER HEALING; BLOOD; COLON; COLONOSCOPY; COMPARATIVE STUDY; DRUG EFFECT; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RECTAL DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME; ULCERATIVE COLITIS; WOUND HEALING;

ADMINISTRATION, RECTAL; ADULT; AGED; AGED, 80 AND OVER; ALANINE; COLITIS, ISCHEMIC; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; ENEMA; FASTING; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; QUINOLONES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 53449085492     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4059     Document Type: Article

References (35)

1. Boley SJ, Schwartz S, Lash J, Sternhill V. Reversible vascular occlusion of the colon. Surg Gynecol Obstet 1963; 116: 53-60
2. Marston A, Pheils MT, Thomas ML, Morson BC. Ischaemic colitis. Gut 1966; 7: 1-15
3. Tohda G, Higashi S, Sumiyoshi K, Sakumoto H, Kato C, Kane T. Evaluation of clinical features of ischemic colitis: comparison between young and elderly. Dig Endosc 2005; 17: 123-130
4. Collet T, Even C, Bouin M, Lecluse E, Piquet MA, Crampon D, Grollier G, Dao T, Verwaerde JC. Prevalence of electrocardiographic and echocardiographic abnormalities in ambulatory ischemic colitis. Dig Dis Sci 2000; 45: 23-25
5. Hourmand-Ollivier I, Bouin M, Saloux E, Morello R, Rousselot P, Piquet MA, Dao T, Verwaerde JC. Cardiac sources of embolism should be routinely screened in ischemic colitis. Am J Gastroenterol 2003; 98: 1573-1577
6. Matsumoto T, Iida M, Kimura Y, Nanbu T, Fujishima M. Clinical features in young adult patients with ischaemic colitis. J Gastroenterol Hepatol 1994; 9: 572-575
7. Habu Y, Tahashi Y, Kiyota K, Matsumura K, Hirota M, Inokuchi H, Kawai K. Reevaluation of clinical features of ischemic colitis. Analysis of 68 consecutive cases diagnosed by early colonoscopy. Scand J Gastroenterol 1996; 31: 881-886
8. Friedel D, Thomas R, Fisher RS. Ischemic colitis during treatment with alosetron. Gastroenterology 2001; 120: 557-560
9. Miller DP, Alfredson T, Cook SF, Sands BE, Walker AM. Incidence of colonic ischemia, hospitalized complications of constipation, and bowel surgery in relation to use of alosetron hydrochloride. Am J Gastroenterol 2003; 98: 1117-1122
10. Welch M, Baguneid MS, McMahon RF, Dodd PD, Fulford PE, Griffiths GD, Walker MG. Histological study of colonic ischaemia after aortic surgery. Br J Surg 1998; 85: 1095-1098
11. Fanti L, Masci E, Mariani A, Chiesa R, Jannello A, Melissano G, Castellano R, Guerini S, Tittobello A. Is endoscopy useful for early diagnosis of ischaemic colitis after aortic surgery? Results of a prospective trial. Ital J Gastroenterol Hepatol 1997; 29: 357-360
12. Green BT, Tendler DA. Ischemic colitis: a clinical review. South Med J 2005; 98: 217-222
13. Matsumoto S, Tsuji K, Shirahama S. Clinical investigation of 41 patients with ischemic colitis accompanied by ulcer. World J Gastroenterol 2007; 13: 1236-1239
14. Arakawa T, Higuchi K, Fujiwara Y, Watanabe T, Tominaga K, Sasaki E, Oshitani N, Yoshikawa T, Tarnawski AS. 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci 2005; 50 Suppl 1: S3-S11
15. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci 1998; 43: 5S-13S
16. Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbarnate-induced antral gastric ulcers in rats. Eur J Pharmacol 1992; 212: 9-13
17. Yoshikawa T, Naito Y, Tanigawa T, Kondo M. Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittel forschung 1993; 43: 363-366
18. Naito Y, Yoshikawa T, Tanigawa T, Sakurai K, Yamasaki K, Uchida M, Kondo M. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic Biol Med 1995; 18: 117-123
19. Sakurai K, Sasabe H, Koga T, Konishi T. Mechanism of hydroxyl radical scavenging by rebamipide: identification of mono-hydroxylated rebamipide as a major reaction product. Free Radic Res 2004; 38: 487-494
20. Okayama M, Tsubouchi R, Nishio H, Kato S, Takeuchi K. Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis. Digestion 2004; 70: 240-249
21. Ishihara K, Komuro Y, Nishiyama N, Yamasaki K, Hotta K. Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung 1992; 42: 1462-1466
22. Makiyama K, Takeshima F, Kawasaki H, Zea-Iriarte WL. Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative. Am J Gastroenterol 2000; 95: 1838-1839
23. Makiyama K, Takeshima F, Hamamoto T. Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: a prospective study report. Dig Dis Sci 2005; 50: 2323-2329
24. Furuta R, Ando T, Watanabe O, Maeda O, Ishiguro K, Ina K, Kusugami K, Goto H. Rebamipide enema therapy as a treatment for patients with active distal ulcerative colitis. J Gastroenterol Hepatol 2007; 22: 261-267
25. Miyata M, Konagaya T, Kakumu S, Mori T. Successful treatment of severe pouchitis with rebamipide refractory to antibiotics and corticosteroids: a case report. World J Gastroenterol 2006; 12: 656-658
26. Kaneko E, Hoshihara Y, Sakaki N, Harasawa S, Ashida K, Asaka M, Asaki S, Nakamura T, Kobayashi K, Kajiyama G, Ogawa N, Yao T, Muto Y, Nakazawa S, Takemoto T. Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor. J Gastroenterol 2000; 35: 824-831
27. Kleine A, Kluge S, Peskar BM. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 1993; 38: 1441-1449
28. Sun WH, Tsuji S, Tsujii M, Gunawan ES, Kawai N, Kimura A, Kakiuchi Y, Yasumaru M, Iijima H, Okuda Y, Sasaki Y, Hori M, Kawano S. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide a mucoprotective agent. J Pharmacol Exp Ther 2000; 295: 447-452
29. Murata H, Yabe Y, Tsuji S, Tsujii M, Fu HY, Asahi K, Eguchi H, Kawano S, Hayashi N. Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells. Dig Dis Sci 2005; 50 Suppl 1: S70-S75
30. Farhadi A, Keshavarzian A, Fitzpatrick LR, Mutlu E, Zhang Y, Banan A. Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide. Dig Dis Sci 2002; 47: 1342-1348
31. Niwa Y, Nakamura M, Omiya N, Itoh A, Hirooka Y, Goto H. Ileal cancer and erosions in the small intestine revealed by capsule endoscopy. Endoscopy 2007; 39 Suppl 1: E7-E8
32. Ichihara T, Nagahata Y, Urakawa T, Saitoh Y. [Experimental study on the etiology of ischemic colitis] Nippon Geka Gakkai Zasshi 1994; 95: 7-13
33. Sakurai K, Yamasaki K. Protective effect of rebamipide against hydrogen peroxide-induced hemorrhagic mucosal lesions in rat stomach. Jpn J Pharmacol 1994; 64: 229-234
34. van Bodegraven AA, Boer RO, Lourens J, Tuynman HA, Sindram JW. Distribution of mesalazine enemas in active and quiescent ulcerative colitis. Aliment Pharmacol Ther 1996; 10: 327-332.
35. Otten MH, De Haas G, Van den Endo R. Colonic spread of 5-ASA enemas in healthy individuals, with a comparison of their physical and chemical characteristics. Aliment Pharmacol Ther 1997; 11: 693-697